Life Sciences

Collagen Solutions Plc

Collagen Solutions develops, manufactures and supplies medical-grade collagen biomaterials for use in research, medical devices, and regenerative medicine. The company provides product development and contract manufacturing services, including technology transfer and regulatory support. Customers include some of the largest pharmaceutical and medical device companies in the world.

The markets in which it operates are substantial; potentially as much as $16bn. Given its manufacturing know-how and recent access to next generation collagen processing IP, which is expected to lead to new development and manufacturing contracts, the opportunity for enhancing the value of this business is considered substantial.

Market: AIM

Ticker: COS

www.collagensolutions.com/

Lead analyst: Dr Martin Hall